LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: The use of electroporation to deliver DNA-based vaccines.

Kisakov, Denis N / Belyakov, Igor M / Kisakova, Lubov A / Yakovlev, Vladimir A / Tigeeva, Elena V / Karpenko, Larisa I

Expert review of vaccines

2023  Volume 23, Issue 1, Page(s) 102–123

Abstract: Introduction: Nucleic acids represent a promising platform for creating vaccines. One disadvantage of this approach is its relatively low immunogenicity. Electroporation (EP) is an effective way to increase the DNA vaccines immunogenicity. However, due ... ...

Abstract Introduction: Nucleic acids represent a promising platform for creating vaccines. One disadvantage of this approach is its relatively low immunogenicity. Electroporation (EP) is an effective way to increase the DNA vaccines immunogenicity. However, due to the different configurations of devices used for EP, EP protocols optimization is required not only to enhance immunogenicity, but also to ensure greater safety and tolerability of the EP procedure.
Area covered: An data analysis for recent years on the DNA vaccines delivery against viral and parasitic infections using EP was carried out. The study of various EP physical characteristics, such as frequency, pulse duration, pulse interval, should be considered along with the immunogenic construct design and the site of delivery of the vaccine, through the study of the immunogenic and protective characteristics of the latter.
Expert opinion: Future research should focus on regulating the humoral and cellular response required for protection against infectious agents by modifying the EP protocol. Significant efforts will be directed to establishing the possibility of redirecting the immune response toward the Th1 or Th2 response by changing the EP physical parameters. It will allow for an individual selective approach during EP, depending on the pathogen type of an infectious disease.
MeSH term(s) Humans ; Vaccines, DNA ; Electroporation/methods ; DNA
Chemical Substances Vaccines, DNA ; DNA (9007-49-2)
Language English
Publishing date 2023-12-18
Publishing country England
Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
ZDB-ID 2181284-6
ISSN 1744-8395 ; 1476-0584
ISSN (online) 1744-8395
ISSN 1476-0584
DOI 10.1080/14760584.2023.2292772
Shelf mark
Zs.A 6077: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top